List ---> Gluten Free Alcohol Beverages *UPDATED*

GLUTEN-FREE ALCOHOL BEVERAGES - Updated July 30, 2013
Updates for 7/13 are in red

• Amaretto - Disaronno Originale Amaretto, Hiram Walker
  
• Anisette - Hiram Walker
  
• *Bacardi Silver products NOT gluten-free
  
• Beer - Redbridge, Bard's Tale Dragon's Gold, Bard's Tale Tavern Ale - coming soon,New Grist, Schlafly Gluten-free Ale, Green's (many flavors), Shakparo Ale (Sprecher Brewery), Mbege (Sprecher Brewery), Honey Beer (Ramapo Valley Brewery), La Messagère & Messagere Red Ale (Canada), Birra 76 Bi-Aglut (Italy), O’Brien Premium Lager, Pale Ale & Brown Ale (O'Brien Brewing, Australia), Glutaner (Mongozo BV - sold in 15 countries - not yet sold in the U.S.), Budweiser *lime*G-Free Beer,

• Blue Curacao - Hiram Walker
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
• 
  
• Brandy -  Hiram Walker
  
• Cafe Aztec - Hiram Walker
  
• Champagne, Wine, and Sparkling Wines
  
• Cognac - Martell (email 8/22/08)
  
• Cointreau
  
• Diageo - "Diageo products, which have been distilled, do not contain glutens or gluten residues, Captain Morgan Rums are gluten free but not the Flavored Malt Beverages..." (email 01/28//09)
  
• Dr. McGillicuddy - "the alcohol is sourced from corn products" -"We do not knowingly add any gluten-containing products, but can not certify that they are gluten free." (01/30/09)
  
• E. & J. Gallo Winery  U.S. products are all gluten-free (email 12/2/11)
  
• Gin - Beefeater Gin (gluten-free but made from wheat, email 8/11/08), Cold River (potato based)
  
• Grand Marnier
  
• Hiram Walker no gluten present in Hiram Walker products (website FAQ 1/26/09)
  
• Horsby's Hard Cider all gluten-free (email 12/2/11)
  
• Jägermeister "On basis of current analyses Jägermeister can be considered free from gluten, starch and lactose." (email 12/15/09)
  
• Kahlua
  
• Kirschwasser - Hiram Walker
  
• Rum - Pyrat Rum XO Reserve (email 9/26/11), Bacardi (*Bacardi Silver products NOTgluten-free), Captain Morgan, Havana Club (all varieties, email 1/14/10), Cacique Rum, Malibu Rum (email 8/31/10)
  
• Sambuca - Hiram Walker
  
• Schnapps - all Hiram Walker
  
• Scotch
  
• Sparkling Wine
  
• Tequila - Patron (Silver, Reposado, Anejo, Gran Patron Platinum, Gran Patron Burdeos,Citronge, XO Café) email 9/26/11), Cazadores Reposado, *Jose Cuervo Tradicional,  Sauza Tequilas (email 6/9/08), Cabo Wabo, any 100% Agave, Including White Tequila by Albertson's, Acme, Jewel, Equaline Good Day Labels (mail 5/21/08)  
  

       *Jose Cuervo website states that all Jose Cuervo tequilas, Authentic      
       Cuervo Margaritas, Margarita Minis, and Golden Margaritas are gluten-free. *Don Julio products are NOT gluten-free - 

• Triple Sec - Hiram Walker
  
• Vermouth
  
• Vodka - Smirnoff (made from corn), Smirnoff Citrus Twist, UV Vodka (corn), Rain Organics Vodka (made from 100% organic white, corn), Ciroc (grapes), Chopin, Luksusowa, Teton Glacier, Zodiac, Bushman's, Hampton's, Kamchatka, Popov Citrus & Popov Tangerine, Reisk, Monopolowa, Ketel One (gluten-free but is made from 100% wheat), Beak & Skiff Vodka (distilled from apples), Blue Ice Vodka (potato vodka), Bombora (Australian grape based), Boyd & Blair (potato based), Cold River Potato Vodka, Famous Vodka (potato based), Krome Vodka (corn based), RWB Vodka (potato), Tito's Handmade Vodka (corn), Vikingfjord Vodka (potato),  
  
• 
  
• 
  
• Wine - all except wine coolers made with malt
  
• 
  
• Whiskey - Queen Jenny Whiskey
• Bourbon - Hudson Bay Bourbon (corn)
• Hard Cider - ACE Cider, Crispin Cider, Magners Cider, Strongbow Cider, Woodchuck Cider, McKenzie's Cider
• Sake - All varieties (rice based)

List Referenced from: http://www.glutenfree-lifestyle.com/gluten-free-alcohol-beverages.html

Probiotic Drink - Brings Relief To IBS Sufferers

Sounds gross but promising to bring relief to IBS sufferers.  Made in the UK and available over the counter and found online for purchase.  Tesco stores also supply this probiotic drink, Symprove.

 £2 drink that could ease IBS misery for millions available over the counter

The £2 Symprove drink could provide relief for millions of IBS sufferers

British doctors are claiming a major breakthrough in treating a stomach condition which causes misery for millions.
They proved that a drink containing ‘friendly’ bugs relieves bloating and stomach pain for long-term sufferers of irritable bowel syndrome.
Around 12million people in the UK are affected by IBS. Three in four sufferers are women.
The probiotic drink called  Symprove is already available online and in some Tesco stores and a daily dose costs around the same as a cappuccino at £2.
The study, run to the same standard as a drugs trial and sponsored by King’s College Hospital, London, involved 186 people, aged 18 to 65, who had been diagnosed with moderate to severe IBS.
Two-thirds of patients were given Symprove and the rest drank a placebo for 12 weeks.The results showed that Symprove was effective in reducing the severity of a range of symptoms, particularly constipation and diarrhoea, with patients feeling less pain and discomfort at the end of the trial and four weeks later.

The drink is already available online and in some Tesco stores

More than one in five receiving the probiotic drink saw their symptoms fall from the severe category to mild.
Researchers said many people eat yoghurts and other probiotic products to promote a healthy gut, but the majority do not have the ‘robust evidence’ for improving IBS symptoms.
They presented their findings at a medical conference in San Diego last week.
Professor Ingvar Bjarnason, who led the study, added: ‘The Symprove trial is a real breakthrough for IBS sufferers.’

Read more: http://www.dailymail.co.uk/health/article-2150878/Drink-ease-IBS-misery-millions--2-stomach-treatment-available-shelves-near-you.html#ixzz1w9rn0o00

IBD Risk Factors - Research Studies 4 Factors That Could Help IBD Patients

Good read!                    Research studies on the following:

• High-Altitude Journeys and Flights Are Associated with the Increased Risk of Flares in IBD Patients (Abstract #303) 

• Reproductive Factors and Risk of Ulcerative Colitis and Crohn's Disease: Results from Two Large Prospective Cohorts of U.S. Women (Abstract #402)  
• PIANO: A 1000 Patient Prospective Registry of Pregnancy Outcomes in Women with IBD Exposed to Immunomodulators and Biologic Therapy (Abstract #865)

• Environmental Risk Factors for Crohn's Disease: Maltodextrin (MDX), a Ubiquitous Dietary Additive in Western Diets, Enhances Biofilm Formation and Adhesivness of E. coli (Abstract #Tu1844)

New research identifies possible risk factors, treatments for bowel

NEW Treatments for Crohn's, MS, Autoimmune Diseases - Good Read!

Good reading about 2 treatments in the making to treat diseases 

such as MS, IBD & Type 1 diabetes.  This is the 1st I've read about 

this treatment. They discuss a lot of financial aspects in this article, but 

also explain how these treatments work to halt abnormal immune function .  

Intrepid Investors Eye Use Of Pig Whipworm Eggs To Quell Crohn's Disease and MS

Dr. Lindsay Rosenwald is a familiar name on Wall Street, a long-time investor with 23 years of experience as a biotechnology entrepreneur, instrumental in founding and recapitalizing a large number of public and private life sciences companies, including Cougar Biotechnology which was acquired by Johnson & Johnson for $1 billion in 2009.

The latest company he has formed is again catching the eye of biotech investors: Coronado Biosciences (CNDO), which is developing two therapies that alter the activity of the immune system. Its probiotic treatment consists of “Trichuris suis ova (TSO),” or non-infectious porcine whipworm eggs, to quell inflammation and abnormal immune function that causes such autoimmune diseases as multiple sclerosis (MS), inflammatory bowel disease, and type 1 diabetes.

“The lead indication is Crohn’s Disease, though MS is not far behind,” says Dr. Keith A. Markey, life sciences analyst at investment firm Griffin Securities. Its second program, he notes, relies on a proprietary method to activate natural killer cells of the innate immune system to combat cancer. Those killer cells, which have shown promise against solid and hematological malignancies, are being developed to treat acute myeloid leukemia, says the analyst.

“Coronado has a proprietary method of activating the killer cells ‘ex vivo’ to create a personalized medicine for a variety of malignancies, says Dr. Markey. Coronado is collaborating with European companies on the probiotic project and will likely seek other foreign companies to market its natural killer-cells therapy, he adds.

Joseph Pantginis, biotech analyst at Roth Capital Partners, is also high on Coronado’s two therapies. “We see significant potential with Coronado’s two clinical programs, based on encouraging preliminary signs of efficacy and favorable safety,” he says. The analyst expects the launch of a Phase 2 study of TSO in patients with Crohn’s disease in the second quarter of this year, while interim data from a randomized Phase 2 study conducted by Coronado’s partner, Dr. Falk Pharma, is also expected to be announced sometime within that period.

Pantginis rates Coronado’s stock, currently trading on the NASDAQ at $7.44 a share, as a buy with a price target of $24, based in part on his belief that Coronado represents a significant value on TSO’s potential to address large market, if not blockbuster, opportunites.

Dr. Bobby W. Sandage Jr., president and CEO of Coronado, says that results from a series of proof-of-principle clinical studies have demonstrated that TSO is “safe and well tolerated with no side effects or complications.” He says the use of pig whipworm eggs represents a novel approach to treating autoimmune diseases. Sandage says the company has licensed numerous patents in the field to gain exclusive rights to commercialize the technology in North America, South America and Japan.

Griffin’s analyst Dr. Markey says epidemiological data suggest that parasitic worms have played an important yet unappreciated role in helping to hold the human immune system in check. As living standards have improved over the past 100 years and medicines developed to treat helminth infections, autoimmune diseases have become more common.

Preclinical studies have shown, says Dr. Markey, that helminths (parasitic worms) use various mechanisms to protect themselves from detection and attack by the human immune system. Coronado’s therapy, Dr. Market notes, which consists of eggs of the pig whipworm TSO, takes advantage of the natural protective mechanisms of helminths, which have evolved over eons, to treat intractable diseases. Just as important, he adds, the ova or eggs pose no threat to humans as they are not infectious and cannot be spread from one person to another.

These huge, under-served markets offer large potential returns on Coronado’s R&D investments. Dr. Markey says Coronado is “developing its helminth therapy to treat autoimmune diseases that have failed to respond well to medicines thus far.” Yet they affect the daily lives of an estimated 10% of the world’s population, he says.

The difference between Coronado’s approach and traditional therapy is that the new treatment is able to “respond in a multi-faceted manner and perhaps dynamically to an aberrant immune system.” Given the “limited success of today’s drugs, the size of the patient populations, and the unique traits of helminths, it seems likely that Coronado’s R&D investments will yield above-average returns,” says Dr. Markey. Coronado’s CNDO-201 treatment is being developed as a first-line therapy for Crohn’s Disease and Multiple Sclerosis, notes the analyst.

Coronado’s other product, CNDO-109, involving the natural killer cells, is another logical choice for combating cancer, he says. It stems from early work conducted at the National Cancer Institute, based on a proprietary method of activating key cells of the innate immune system. Natural killer cells normally play an important role in inducing apoptosis of cancerous cells and others that have been infected with viruses.

Coronado’s therapy activates the cells ex vivo and then administers those cells to the patient. Results of a Phase 1 study, rcently presented at the 2011 Annual Meeting of the American Society of Hematology, showed three of five patients in their second or third remissions had longer complete responses with CNDO-109 than with other therapies, says Dr. Markey. This is an unusual activty as acute myeloid leukemia is characterized by progressively shorter remission periods regardless of the drug regimen, says the analyst.

“We believe Coronado Bioscience stock is an attractive long-term holding,” says Dr. Markey. Its two development programs, he says, take advantage of the natural characteristics of TSO and the natural killer cells to address serious medical conditions, and as such “we believe they carry less risk than that of traditional drug development projects.”

Health Expert -Jake Wilson States Advantages of Taking Probiotics for: Acute diarrhea & more

The many benefits of taking probiotics regularly.  

Some Article Highlights:

"As a result from taking antibiotics, absorption of fatty acids and glucose are interrupted and osmotic diarrhea ensues along with the immune system’s efforts to flush out contaminants. With probiotics, the chance of suffering through the condition is lessened by 42%

 "the combination of multiple bacterial strains in probiotics have been guaranteed to lessen the duration of diarrhea as well as the frequency of defecation."

"Prolonged antibiotic treatment also makes folks susceptible to Clostridium difficile overgrowth – which is another major cause of digestive problems.
Introduction of Lactobacillus, for example, in the system is more than a welcome alternative to the usual protocols as it not only reduces the chance of antibiotic-associated diarrhea but also enhances the immune system and improves stool consistency"

I would recommend Metagenics for a trusted & high quality probiotic.  

 http://www.metagenics.com/

Probiotics Help Minimize Diarrhea After Eating Or Taking In Antibiotics

Health expert Jake Wilson confirms that intake of probiotic can help lessen the chances of diarrhea after eating or taking some of its known causes.
Over the years, there have been several reported triggers for acute diarrhea – from stress, to food, to medication and underlying diseases. According to recent studies, probiotics can now help minimize the impact antibiotics have on a person’s digestive system.
As we all know, antibiotics are made to combat and destroy microorganisms that have invaded the body. But when they attack, they usually do not care about the casualties. This, in turn affects carbohydrate metabolism since some colonic bacteria are wiped out by the therapy. As a result, absorption of fatty acids and glucose are interrupted and osmotic diarrhea ensues along with the immune system’s efforts to flush out contaminants. With probiotics, the chance of suffering through the condition is lessened by 42%, and it doesn’t even matter what infectious agent might be involved.
Probiotics are actually strains of “good” bacteria that help replace the normal intestinal bacteria wiped out by antibiotics. They come in a variety of forms and can be taken in through a number of measures. Although the studies have not yet analysed conclusively which type of probiotic provides more benefits, the combination of multiple bacterial strains have been guaranteed to lessen the duration of diarrhea as well as the frequency of defecation.
According to Diarrhea After Eating, a health and wellness resource site, 25% to 33% of people treated with antibiotic typically get diarrhea as an adverse effect. And for the most part, it is an expected consequence to the treatment. But for those patients who are very weak and are unable to effectively nourish themselves, losing water and electrolytes because of it may prove fatal. Prolonged antibiotic treatment also makes folks susceptible to Clostridium difficile overgrowth – which is another major cause of digestive problems.
Introduction of Lactobacillus, for example, in the system is more than a welcome alternative to the usual protocols as it not only reduces the chance of antibiotic-associated diarrhea but also enhances the immune system and improves stool consistency. Of course, it does not have any influence over other known triggers of the condition. But at the very least, it is one safe solution people can use.
If you’d like to know more about treatments to diarrhea after eating different kinds of food, visit http://diarrheaaftereatingx.com/.
http://empowerednews.net/probiotics-help-minimize-diarrhea-after-eating-or-taking-in-antibiotics/1823853/

Fiber Reduces Crohn's Disease Risk in Woman

Fiber Cuts Crohn's Risk in Women

By Nancy Walsh, Staff Writer, MedPage Today

Published: May 23, 2012

Reviewed by Dori F. Zaleznik, MD; Associate Clinical Professor of Medicine, Harvard Medical School, Boston.

Action Points

• This study was published as an abstract and presented at a conference. These data and conclusions should be considered to be preliminary until published in a peer-reviewed journal.
• Women prospectively followed in the Nurses' Health Study I and II were found to have a lower risk of Crohn's disease if they consumed a diet high in fiber from vegetables and fruit, but not from cereals or whole grains.
• Note that high soluble or insoluble fiber intake was not found to influence the risk of ulcerative colitis.

SAN DIEGO -- High fiber intake was associated with a 38% reduction in risk of Crohn's disease in women, a researcher reported here.

Data from the Nurses' Health Study I and II showed the hazard ratio for Crohn's disease among women whose fiber intake was highest was 0.62 (95% CI 0.40 to 0.95) compared with those consuming the lowest amount of fiber, said Ashwin N. Ananthakrishnan, MBBS, of Massachusetts General Hospital in Boston.

Crohn's disease is believed to result from a combination of genetic and environmental factors, and some evidence suggests that dietary fiber may play a role, possibly through effects on the gut microflora, epithelial barrier function, and the prevention of bacterial translocation.

However, previous studies have been retrospective in design, included small numbers, and were subject to recall bias.

To prospectively investigate the effects of fiber on inflammatory bowel disease, Ananthakrishnan and colleagues analyzed data from 164,248 women in the Nurses' Health Study.

During 3,010,426 person-years of observation, there were 248 cases of Crohn's disease, for an incidence rate of 8 per 100,000 person-years, and 308 cases of ulcerative colitis, with an incidence rate of 10 per 100,000. Self-reports of these diagnoses were confirmed with a review of patients' medical records.

The median age of the Crohn's patients was 54, and the ulcerative colitis patients were 2 years younger.

Intake of various types of food was assessed every 2 years on a validated food frequency questionnaire. Patients in the lowest quintile of fiber intake averaged 11 grams per day, while those in the highest quintile consumed 25 grams per day.

The risk of Crohn's disease in the highest quintile was primarily lowered with consumption of soluble fiber:

• Fruit, HR 0.55 (95% CI 0.36 to 0.83)
• Vegetables, HR 0.72 (95% CI 0.48 to 1.06)
• Cruciform vegetables, HR 0.73 (95% CI 0.50 to 1.08)

The trend toward significance for cruciform vegetables suggested a role for the aryl hydrocarbon receptor in risk reduction, the researcher said.

In contrast, consumption of insoluble fiber did not decrease risk:

• Cereals, HR 0.89 (95% CI 0.58 to 1.35)
• Whole grains, HR 1.04 (95% CI 0.67 to 1.61)

There was no observed dose response among women in the medium quintiles of fiber intake, with the risks for the second and fourth quintile being quite similar.

"There may be a threshold effect," Ananthakrishnan said.

Unlike for Crohn's disease, increased fiber intake had no effect on risk for ulcerative colitis, with a hazard ratio of 0.88 (95% CI 0.60 to 1.28) in women with the highest level of consumption. Intake from the various specific sources of fiber also was not associated with a reduction in risk for ulcerative colitis.

Limitations of the study included its inclusion of mostly white women and their older age.

Further research is warranted to explore the biological mechanisms by which fiber influences the risk for Crohn's disease, Ananthakrishnan concluded.